HNRNPM (Heterogeneous Nuclear Ribonucleoprotein M) is an RNA-binding protein that plays essential roles in pre-mRNA processing, mRNA splicing, and translational regulation. The protein is encoded by the HNRNPM gene on chromosome 19p13.3 and belongs to the heterogeneous nuclear ribonucleoprotein (hnRNP) family, a group of proteins that associate with nascent pre-mRNAs in the nucleus. HNRNPM contains multiple RNA recognition motifs (RRMs) that enable it to bind specific RNA sequences and regulate post-transcriptional gene expression.
The 730-amino acid protein is involved in alternative splicing decisions, mRNA stability, and translation efficiency. Recent studies have implicated HNRNPM in neurodegenerative diseases, particularly ALS and frontotemporal dementia, where RNA metabolism dysregulation is a key pathological feature. The protein's ability to regulate splicing of disease-relevant transcripts makes it a molecule of interest for understanding neurodegeneration mechanisms.
- Protein Name: HNRNPM - Heterogeneous Nuclear Ribonucleoprotein M
- UniProt ID: P61326
- Gene: HNRNPM
- Molecular Weight: ~77 kDa (730 amino acids)
- Protein Class: RNA-binding protein, Splicing factor
- Tissue Expression: Ubiquitous, high in brain, muscle
- Subcellular Localization: Nucleus (speckles, nucleolus), cytoplasm
HNRNPM has a complex multi-domain architecture:
- Three RNA recognition motifs (RRMs): RRM1, RRM2, RRM3 in central region
- Glycine-rich region: Potential protein-protein interaction domain
- N-terminal region: Regulatory and interaction surfaces
- C-terminal acidic domain: May mediate interactions with other hnRNPs
- Nuclear localization signals: NLS sequences for nuclear import
The arrangement of RRMs allows for recognition of diverse RNA sequences, and the protein can also interact with other splicing factors through its glycine-rich domain.
HNRNPM performs diverse RNA-processing functions:
- Alternative splicing: Regulates inclusion/exclusion of specific exons
- Pre-mRNA binding: Associates with nascent pre-mRNA transcripts
- mRNA stability: Modulates mRNA half-life through binding
- Translation regulation: Affects translational efficiency of target mRNAs
- Transcript-specific regulation: Controls splicing of specific disease-relevant transcripts
- Nuclear-cytoplasmic transport: Involved in mRNA export
HNRNPM can function as both a splicing activator and repressor depending on the context and binding site location relative to regulated exons.
- RNA metabolism: Global disruption of RNA processing in ALS
- Splicing dysregulation: Alters splicing of ALS-related transcripts
- Stress granules: Incorporated into stress granules under stress
- TDP-43 pathology: Interacts with TDP-43 in RNA granules
- FTD pathology: Altered HNRNPM in FTD brain
- RNA granule dynamics: Disrupted stress response
- Alternative splicing: Aberrant splicing patterns
- Alzheimer disease: Possible HNRNPM alterations
- Spinal muscular atrophy: Connection to splicing machinery
- Splicing modifiers: Compounds that restore proper splicing patterns
- RNA-targeted approaches: Modulate HNRNPM activity
- Gene therapy: Restore proper HNRNPM function
- Dreyfuss G et al., hnRNP proteins and RNA processing (2002)
- Hentze MW et al., A brave new world of RNA-binding proteins (2018)
- Liu-Yesucevitz L et al., ALS RNA granules (2010)